LSV Asset Management’s Boston Scientific BSX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q3
Sell
-4,200
Closed -$451K 893
2025
Q2
$451K Hold
4,200
﹤0.01% 686
2025
Q1
$424K Buy
+4,200
New +$423K ﹤0.01% 700
2014
Q2
Sell
-148,300
Closed -$2M 873
2014
Q1
$2M Sell
148,300
-9,400
-6% -$123K ﹤0.01% 572
2013
Q4
$1.9M Sell
157,700
-10,200
-6% -$121K ﹤0.01% 573
2013
Q3
$1.97M Sell
167,900
-199,500
-54% -$2.16M 0.01% 578
2013
Q2
$3.4M Buy
+367,400
New +$3.12M 0.01% 504

Other funds holding BSX

LSV Asset Management's BSX Position: Q3 2025 in Review

LSV Asset Management sold out of Boston Scientific (BSX) in Q3 2025, closing a stake of 4,200 shares — an estimated $451K sold.

LSV Asset Management first reported a position in BSX in Q2 2013 and held it in 6 quarters. The position peaked at $3.4M in Q2 2013. 1,715 funds tracked by Wall St. Rank hold BSX as of Q3 2025.

  • LSV Asset Management reported no remaining Boston Scientific position as of Q3 2025 after selling out during the quarter.
  • LSV Asset Management sold 4,200 Boston Scientific shares in Q3 2025, an estimated $451K.
  • LSV Asset Management first reported a position in Boston Scientific in Q2 2013 and held it in 6 quarters.
  • LSV Asset Management's Boston Scientific position peaked at $3.4M in Q2 2013.
  • 1,715 funds tracked by Wall St. Rank held Boston Scientific as of Q3 2025.

Based on LSV Asset Management's 13F filing for Q3 2025, filed 6 Nov 2025.